Zurich Cantonal Bank’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-10,291
| Closed | -$701K | – | 2965 |
|
|
2022
Q3 | $701K | Sell |
10,291
-34,145
| -77% | -$2.33M | ﹤0.01% | 989 |
|
|
2022
Q2 | $1.42M | Sell |
44,436
-147
| -0.3% | -$4.7K | 0.01% | 752 |
|
|
2022
Q1 | $1.54M | Sell |
44,583
-1,288
| -3% | -$44.6K | 0.01% | 786 |
|
|
2021
Q4 | $1.34M | Buy |
45,871
+7,099
| +18% | +$208K | 0.01% | 880 |
|
|
2021
Q3 | $988K | Buy |
38,772
+10,741
| +38% | +$274K | 0.01% | 934 |
|
|
2021
Q2 | $982K | Sell |
28,031
-1,178
| -4% | -$41.3K | 0.01% | 900 |
|
|
2021
Q1 | $1.19M | Sell |
29,209
-682
| -2% | -$27.8K | 0.01% | 832 |
|
|
2020
Q4 | $1.3M | Buy |
29,891
+23,205
| +347% | +$1.01M | 0.01% | 855 |
|
|
2020
Q3 | $369K | Hold |
6,686
| – | – | ﹤0.01% | 1235 |
|
|
2020
Q2 | $422K | Buy |
6,686
+1,692
| +34% | +$107K | ﹤0.01% | 1102 |
|
|
2020
Q1 | $255K | Buy |
4,994
+1,180
| +31% | +$60.3K | ﹤0.01% | 1110 |
|
|
2019
Q4 | $303K | Hold |
3,814
| – | – | ﹤0.01% | 1121 |
|
|
2019
Q3 | $185K | Buy |
3,814
+549
| +17% | +$26.6K | ﹤0.01% | 1278 |
|
|
2019
Q2 | $172K | Buy |
3,265
+482
| +17% | +$25.4K | ﹤0.01% | 1309 |
|
|
2019
Q1 | $147K | Sell |
2,783
-324
| -10% | -$17.1K | ﹤0.01% | 1338 |
|
|
2018
Q4 | $128K | Hold |
3,107
| – | – | ﹤0.01% | 1453 |
|
|
2018
Q3 | $118K | Buy |
3,107
+521
| +20% | +$19.8K | ﹤0.01% | 1624 |
|
|
2018
Q2 | $117K | Sell |
2,586
-835
| -24% | -$37.8K | ﹤0.01% | 1562 |
|
|
2018
Q1 | $165K | Buy |
3,421
+516
| +18% | +$24.9K | ﹤0.01% | 1306 |
|
|
2017
Q4 | $114K | Buy |
2,905
+550
| +23% | +$21.6K | ﹤0.01% | 1496 |
|
|
2017
Q3 | $73K | Hold |
2,355
| – | – | ﹤0.01% | 1571 |
|
|
2017
Q2 | $64K | Buy |
2,355
+336
| +17% | +$9.13K | ﹤0.01% | 1619 |
|
|
2017
Q1 | $74K | Buy |
+2,019
| New | +$74K | ﹤0.01% | 1549 |
|